Company Overview

Update
Founded:
2005
Headquarters:
Mainz
Funding:
$5.7M
Categories:
Biotechnology
Description:
Galantos Pharma is a drug development company focusing on new drugs for neurodegenerative diseases such as Alzheimer’s Dementia.

Detailed Description

Update

Galantos Pharma GmbH focuses on the development of drugs for the treatment of Alzheimer’s and other neurodegenerative diseases. It develops a drug for the treatment of mild-to-moderate Alzheimer’s dementia. The company develops a technology platform that is suitable for screening and preclinical validation of drug candidates that are acting on cholinergic and other neuro-receptors and on various brain enzymes. The company was founded in 2005 and is based in Mainz, Germany.

Current Team (1)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    Freiligrathstraße 12

    Mainz, 55131

    DEU